Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

15.02
+0.15001.01%
Post-market: 15.030.0115+0.08%16:55 EDT
Volume:12.00M
Turnover:180.69M
Market Cap:17.23B
PE:-10.36
High:15.45
Open:15.33
Low:14.81
Close:14.87
Loading ...
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 27, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Major Issues Report

8-K - Current report
Jun 23, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Major Issues Report

8-K - Current report
Feb 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 27, 2021

Major Issues Report

8-K - Current report
Oct 27, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 27, 2021

Major Issues Report

8-K - Current report
Jul 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report